Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency

被引:0
|
作者
Carrie L Lucas
Hye Sun Kuehn
Fang Zhao
Julie E Niemela
Elissa K Deenick
Umaimainthan Palendira
Danielle T Avery
Leen Moens
Jennifer L Cannons
Matthew Biancalana
Jennifer Stoddard
Weiming Ouyang
David M Frucht
V Koneti Rao
T Prescott Atkinson
Anahita Agharahimi
Ashleigh A Hussey
Les R Folio
Kenneth N Olivier
Thomas A Fleisher
Stefania Pittaluga
Steven M Holland
Jeffrey I Cohen
Joao B Oliveira
Stuart G Tangye
Pamela L Schwartzberg
Michael J Lenardo
Gulbu Uzel
机构
[1] Molecular Development of the Immune System Section,Department of Laboratory Medicine
[2] Laboratory of Immunology,Division of Monoclonal Antibodies
[3] National Institute of Allergy and Infectious Diseases,Division of Allergy and Immunology, Department of Pediatrics
[4] National Institutes of Health,undefined
[5] Clinical Center,undefined
[6] National Institutes of Health,undefined
[7] Cell Signaling Section,undefined
[8] Genetic Disease Research Branch,undefined
[9] National Human Genome Research Institute,undefined
[10] National Institutes of Health,undefined
[11] Pritzker School of Medicine,undefined
[12] The University of Chicago,undefined
[13] Immunology and Immunodeficiency Group,undefined
[14] Immunology Program,undefined
[15] Garvan Institute of Medical Research,undefined
[16] St. Vincent's Clinical School Faculty of Medicine,undefined
[17] University of New South Wales,undefined
[18] Laboratory of Cell Biology,undefined
[19] Office of Biotechnology Products,undefined
[20] Center for Drug Evaluation and Research,undefined
[21] United States Food and Drug Administration,undefined
[22] University of Alabama at Birmingham,undefined
[23] Laboratory of Clinical Infectious Diseases,undefined
[24] National Institute of Allergy and Infectious Diseases,undefined
[25] National Institutes of Health,undefined
[26] Laboratory of Clinical Infectious Diseases,undefined
[27] Clinical Research Directorate–Clinical Monitoring Research Program,undefined
[28] Science Applications International Corporation–Frederick,undefined
[29] Frederick National Laboratory for Clinical Research,undefined
[30] Radiology and Imaging and Sciences,undefined
[31] Clinical Center,undefined
[32] National Institutes of Health,undefined
[33] Laboratory of Pathology,undefined
[34] National Cancer Institute,undefined
[35] National Institutes of Health,undefined
[36] Laboratory of Infectious Diseases,undefined
[37] National Institute of Allergy and Infectious Diseases,undefined
[38] National Institutes of Health,undefined
[39] Instituto de Medicina Integral Prof. Fernando Figueira,undefined
来源
Nature Immunology | 2014年 / 15卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Lymphocyte function is regulated by phosphatidylinositol-dependent pathways. Uzel and colleagues identify a cohort of immunodeficient patients with hyperactive phosphatidylinositol-3-OH kinase activity due to mutant p110δ subunits, which results in enhanced senescence of cells of the immune system.
引用
收藏
页码:88 / 97
页数:9
相关论文
共 50 条
  • [1] Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency
    Lucas, Carrie L.
    Kuehn, Hye Sun
    Zhao, Fang
    Niemel, Julie E.
    Deenick, Elissa K.
    Palendira, Umaimainthan
    Avery, Danielle T.
    Moens, Leen
    Cannons, Jennifer L.
    Lanai, Matthew Bianca
    Stoddard, Jennifer
    Ouyane, Weiming
    Frucht, David M.
    Rao, V. Koneti
    Atkinson, T. Prescott
    Agharahimi, Anahita
    Hussey, Ashleigh A.
    Folioll, Les R.
    Olivier, Kenneth N.
    Fleisher, Thomas A.
    Pittaluga, Stefania
    Holland, Steven M.
    Cohen, Jeffrey I.
    Oliveira, Joao B.
    Tangye, Stuart G.
    Schwartzberg, Pamela L.
    Lenardol, Michael J.
    Uzel, Gulbu
    [J]. NATURE IMMUNOLOGY, 2014, 15 (01) : 88 - 97
  • [2] Activating mutations in p110δ cause human immunodeficiency and reveal important roles of PI3K in T cell senescence and homeostatic cell death
    Lucas, Carrie
    Lenardo, Michael
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 192
  • [3] Protein Modeling Led to the Discovery that Mutations in the Gene Encoding PI(3) K Catalytic Subunit p110δ (PIK3CD) Cause PASLI (p110δ Activating Mutation Causing Senescent T Cells, Lymphadenopathy, and Immunodeficiency) Disease
    Niemela, Julie E.
    Lucas, Carrie L.
    Kuehn, Hyesun
    Biancalana, Matthew
    Stoddard, Jennifer L.
    Oliveira, Joao Bosco
    Fleisher, Thomas A.
    Uzel, Gulbu
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (03) : 358 - 359
  • [4] Human tumor mutants in the p110α subunit of PI3K
    Liu, Zhenning
    Roberts, Thomas M.
    [J]. CELL CYCLE, 2006, 5 (07) : 675 - 677
  • [5] The antitumor activity of umbelliferone in human renal cell carcinoma via regulation of the p110γ catalytic subunit of PI3Kγ
    Wang, Xue
    Huang, Shuaishuai
    Xin, Xia
    Ren, Yu
    Weng, Guobin
    Wang, Ping
    [J]. ACTA PHARMACEUTICA, 2019, 69 (01) : 111 - 119
  • [6] LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β
    Zhao, Wei-Jun
    Zhu, Liu-Lian
    Yang, Wei-Qiang
    Xu, Shuai-Jun
    Chen, Jie
    Ding, Xiao-Fei
    Liang, Yong
    Chen, Guang
    [J]. CANCER SCIENCE, 2021, 112 (04) : 1624 - 1632
  • [7] The catalytic PI3K isoforms p110γ and p110δ contribute to B cell development and maintenance, transformation, and proliferation
    Beer-Hammer, Sandra
    Zebedin, Eva
    von Holleben, Max
    Alferink, Judith
    Reis, Bernhard
    Dresing, Philipp
    Degrandi, Daniel
    Scheu, Stefanie
    Hirsch, Emilio
    Sexl, Veronika
    Pfeffer, Klaus
    Nuernberg, Bernd
    Piekorz, Roland P.
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 87 (06) : 1083 - 1095
  • [8] The PI-3-Kinase P110α Catalytic Subunit of T Lymphocytes Modulates Collagen-Induced Arthritis
    Montes-Casado, Maria
    Ojeda, Gloria
    Criado, Gabriel
    Rojo, Jose M.
    Portoles, Pilar
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (12)
  • [9] The PI3K p110δ controls T-cell development, differentiation and regulation
    Patton, D. T.
    Garcon, F.
    Okkenhaug, K.
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 167 - 171
  • [10] The PI3K p110δ Isoform Inhibitor Idelalisib Preferentially Inhibits Human Regulatory T Cell Function
    Chellappa, Stalin
    Kushekhar, Kushi
    Munthe, Ludvig A.
    Tjonnfjord, Geir E.
    Aandahl, Einar M.
    Okkenhaug, Klaus
    Tasken, Kjetil
    [J]. JOURNAL OF IMMUNOLOGY, 2019, 202 (05): : 1397 - 1405